. . . . . . . "[In contrast, low CEBPA expression in AML with intermediate-risk karyotype (n=6) seemed to be associated with poor prognosis (not significant). By including this newly developed PCR-assay, we define a subgroup of good-risk patients within the heterogeneous]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-21"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:30+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .